Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
47
LEG Quote, Financials, Valuation and Earnings
Last price:
$9.99
Seasonality move
:
0.17%
Day range:
$9.59 - $9.88
52-week range:
$6.48 - $14.24
Dividend yield:
2.04%
P/E ratio:
--
P/S ratio:
0.31x
P/B ratio:
1.78x
Volume:
1.9M
Avg. volume:
2.7M
1-year change:
-22.02%
Market cap:
$1.3B
Revenue:
$4.4B
EPS (TTM):
-$3.74
Analysts' Opinion
-
Consensus RatingLeggett & Platt has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $10.33, Leggett & Platt has an estimated upside of 5.34% from its current price of $9.81.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $10.00 representing -1.94% downside risk from its current price of $9.81.
Fair Value
-
According to the consensus of 4 analysts, Leggett & Platt has 5.34% upside to fair value with a price target of $10.33 per share.
LEG vs. S&P 500
-
Over the past 5 trading days, Leggett & Platt has underperformed the S&P 500 by -2.74% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Leggett & Platt does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Leggett & Platt revenues have been falling on a year-over-year basis for 11 quarters in a row. In the most recent quarter Leggett & Platt reported revenues of $1B.
Earnings Growth
-
Leggett & Platt earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Leggett & Platt reported earnings per share of $0.22.
Enterprise value:
2.9B
EV / Invested capital:
--
Price / LTM sales:
0.31x
EV / EBIT:
--
EV / Revenue:
0.66x
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
11.42x
Price / Operating cash flow:
5.42x
Enterprise value / EBITDA:
62.36x
Gross Profit (TTM):
$752.7M
Return On Assets:
-13.05%
Net Income Margin (TTM):
-11.89%
Return On Equity:
-61.94%
Return On Invested Capital:
-18.44%
Operating Margin:
6.01%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $5B | $4.6B | $4.3B | $1.1B | $1B | |
| Gross Profit | $928.1M | $821.6M | $752.7M | $186.4M | $190M | |
| Operating Income | $429.8M | $289.3M | $224.1M | $55.6M | $61.4M | |
| EBITDA | $620.2M | $56M | -$288.7M | $96.9M | $95.5M | |
| Diluted EPS | $2.00 | -$1.16 | -$3.74 | $0.23 | $0.22 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.8B | $2.1B | $2B | $1.9B | $1.8B | |
| Total Assets | $4.9B | $5.3B | $5.3B | $4.6B | $3.7B | |
| Current Liabilities | $995.6M | $1.4B | $968.6M | $1.2B | $810.4M | |
| Total Liabilities | $3.5B | $3.7B | $3.6B | $3.3B | $3B | |
| Total Equity | $1.5B | $1.7B | $1.7B | $1.3B | $747.6M | |
| Total Debt | $2B | $2.1B | $2.1B | $2.1B | $1.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $499.1M | $394.4M | $318.6M | -$6.1M | $6.8M | |
| Cash From Investing | -$201.3M | -$65.3M | -$32.3M | -$10.4M | -$6.1M | |
| Cash From Financing | -$264.7M | -$305.1M | -$228.1M | $18.1M | $60M | |
| Free Cash Flow | $379.8M | $292.4M | $249.6M | -$32M | -$6.5M | |
LEG
Sector
Market Cap
$1.3B
$426.2M
Price % of 52-Week High
68.92%
73.88%
Dividend Yield
2.04%
0%
Shareholder Yield
3.75%
4%
1-Year Price Total Return
-22.02%
-11.07%
Beta (5-Year)
0.738
0.767
Dividend yield:
2.04%
Annualized payout:
$0.61
Payout ratio:
-15.94%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$9.95
200-day SMA
Sell
Level
$10.10
Bollinger Bands (100)
Buy
Level
7.79 - 9.67
Chaikin Money Flow
Buy
Level
3.4M
20-day SMA
Buy
Level
$9.58
Relative Strength Index (RSI14)
Buy
Level
54.59
ADX Line
Buy
Level
23.25
Williams %R
Neutral
Level
-43.1755
50-day SMA
Buy
Level
$9.37
MACD (12, 26)
Buy
Level
2.71
25-day Aroon Oscillator
Buy
Level
24
On Balance Volume
Neutral
Level
4.3M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.1422)
Sell
CA Score
(Annual)
Level (-1.6863)
Buy
Beneish M-Score
(Annual)
Level (-3.7619)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (1.862)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Leggett & Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the majority of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett & Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.
Stock Forecast FAQ
In the current month, LEG has received 0 Buy ratings 4 Hold ratings, and 0 Sell ratings. The LEG average analyst price target in the past 3 months is $10.33.
-
Where Will Leggett & Platt Stock Be In 1 Year?
According to analysts, the consensus estimate is that Leggett & Platt share price will rise to $10.33 per share over the next 12 months.
-
What Do Analysts Say About Leggett & Platt?
Analysts are divided on their view about Leggett & Platt share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Leggett & Platt is a Sell and believe this share price will drop from its current level to $10.00.
-
What Is Leggett & Platt's Price Target?
The price target for Leggett & Platt over the next 1-year time period is forecast to be $10.33 according to 4 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is LEG A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Leggett & Platt is a Hold. 4 of 4 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of LEG?
You can purchase shares of Leggett & Platt via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Leggett & Platt shares.
-
What Is The Leggett & Platt Share Price Today?
Leggett & Platt was last trading at $9.99 per share. This represents the most recent stock quote for Leggett & Platt. Yesterday, Leggett & Platt closed at $9.81 per share.
-
How To Buy Leggett & Platt Stock Online?
In order to purchase Leggett & Platt stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
